Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1222, 2000-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Gemcitabine plus vinorelbine superior in NSCLC
Inpharma, Vol. 1, Iss. 1251, 2000-01 ,pp. :
Access to resources
Recommend
Gemcitabine + cisplatin for NSCLC: genotype predicts survival
Inpharma, Vol. 1, Iss. 1540, 2006-01 ,pp. :
Gemcitabine alone or in combination with cisplatin cost effective in NSCLC
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 363, 2002-01 ,pp. :
Aprinocarsen/cisplatin/gemcitabine may have activity in NSCLC
Inpharma, Vol. 1, Iss. 1465, 2004-01 ,pp. :
Gemcitabine plus pemetrexed promising in advanced NSCLC
Inpharma, Vol. 1, Iss. 1460, 2004-01 ,pp. :